Clinical news - results | Chemist+Druggist

News | All clinical

Refine

The supply shortages of ranitidine are having an “immense impact”, one pharmacist said

Ranitidine recall: How have manufacturers and pharmacists responded?

Certain batches of ranitidine-containing medicines have been subject to recall and quarantine, as the Medicines and Healthcare products Regulatory...

14/11/2019 6

Canabis-based medicines can only be prescribed by “specialist doctors”

First two cannabis-based medicines recommended for NHS use

Guidance issued by Nice today (November 11) recommends the prescribing of oromucosal spray Sativex for the treatment of moderate-to-severe spasticity...

11/11/2019 0

Demand and packaging issues behind MMR jab and misoprostol export ban

Measles, mumps and rubella (MMR) vaccines, pneumococcal polysaccharide vaccines (PPVs), alogliptin with metformin and misoprostol were added to the...

08/11/2019 1

DH: MMR vaccines and alogliptin with metformin cannot leave UK

Wholesalers are also restricted from exporting pneumococcal polysaccharide vaccines (PPVs) and misoprostol – which is commonly used in the induction...

05/11/2019 3

3 strengths of ranitidine among final 18 price concessions for October

An initial nine price concessions for the month were announced on October 21 and a further 13 concessionary prices were agreed on October 24. Drug...

01/11/2019 1

DH extends shortage protocol for fluoxetine 30mg and 40mg to November

The SSP for fluoxetine 40mg capsules has been extended to November 11, while the protocol for fluoxetine 30mg capsules will continue until November...

30/10/2019 0